Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Regulatory Updates
Page 9
Regulatory Updates
Regulatory Updates
Mobocertinib Granted Conditional Marketing Authorization in Great Britain
Editorial Team
-
March 19, 2022
Olaparib as adjuvant Treatment in Germline BRCA-mutated HER2-negative High-risk Early Breast Cancer
European Medicines Agency Recommends Approval of Enfortumab Vedotin Monotherapy in Bladder Cancer
U.S. FDA approves Phase 3 Study Design for Zilovertamab in the Treatment of Mantle Cell Lymphoma
Tisotumab Vedotin Approved for the Treatment of Recurrent or Metastatic Cervical Cancer
New Data Supports Use of Real-World Evidence to Assess Long-term Impact...
Peter Hofland, Ph.D
-
July 10, 2018
Why Do We Need a Right-to-Try Bill in America?
Jane Orient
-
June 12, 2018
U.S. FDA Grants Accelerated Approval for Neoadjuvant use of Pertuzumab in...
Editorial Team
-
October 1, 2013
Accelerated Approval of Pertuzumab for Neoadjuvant Treatment in High-risk, HER2-Positive Early...
Editorial Team
-
September 13, 2013
Timesaving, Subcutaneous Formulation of Trastuzumab for the Treatment of HER2-positive Breast...
Editorial Team
-
September 3, 2013
U.S. FDA Approves Lenalidomide for the Treatment of Patients with Mantle...
Editorial Team
-
June 7, 2013
Erlotinib is the First Personalized Medicine Approved for the Initial Treatment...
Editorial Team
-
May 15, 2013
Multinational Harmonization and Collaboration Needed – Regulators and Hospital Urged to...
Editorial Team
-
January 28, 2013
Deferasirox Approved by European Commission for Iron Overload in Patients with...
Editorial Team
-
December 22, 2012
European Medicines Agency Offers Positive Opinion Bevacizumab Based Treatment Beyond First...
Shaun Mehr, Associate Publisher
-
November 16, 2012
1
...
8
9
10
Page 9 of 10
LATEST NEWS
Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth
Editorial Team
-
June 22, 2022
Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells
Editorial Team
-
June 21, 2022
Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...
Editorial Team
-
June 20, 2022
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Michelle Andrews
-
June 14, 2022
Pioneering Novel Targeted Treatments in Lung Cancer
Editorial Team
-
June 10, 2022
X